Today's Date: March 28, 2024
Boston Children’s Hospital and NRG Energy celebrate $1 million milestone, thanks to the Choose to Give program   •   Green Boom Expands Product Line to The Home Depot   •   Jack Link’s® Unveils a Sweet Collaboration with Dr Pepper® That Brings Two Classic Tastes Together   •   Reveal Technology, Inc. Receives $3.2M Award With U.S. Marine Corps Warfighting Laboratory (MCWL)   •   /R E M I N D E R -- Travelling for Easter? The Canada Border Services Agency gives tips for a smooth trip/   •   Yiwugo Embraces Surge in Demand for Chinese Trendy Products: Hanfu & Handcrafted Beads in Vogue   •   Yamaha Motor Signs Technical Partnership with Lola Cars for Development and Supply of Powertrains for Formula E   •   Morningstar Publishes Fourth Annual Corporate Sustainability Report   •   Tractor Supply Opens Applications for Second Annual Open Buying Days Event   •   From Tee to Triumph: Teen Entrepreneur and Golf Sensation Hosts First Annual Autism Awareness Golf Tournament   •   BMO Recognized for Gender Equity by Report on Business' Women Lead Here List 2024   •   In 23rd Annual Sexual Assault Awareness Month Campaign, NSVRC Calls for Building Connected Communities to Prevent Sexual Violenc   •   Modern Health & Naomi Osaka’s Hana Kuma Launch Mental Health Focused Video Podcast Series “Can’t Wait To H   •   Guaranteed Rate Welcomes New Atlanta Branch Manager, Carlos Mata   •   ComPsych Corporation Announces 2023 Health at Work Award Winners   •   ElementalTV and Spanglish Movies Partner to Accelerate US Hispanic Market Activations in CTV Advertising: 'Spanglish Audiences'   •   Leading In-Home Care Franchise Looks to Expand in La Crosse   •   Lutheran Senior Services and Diakon Enter Into Senior Living Agreement   •   Join Us as We Stand Together and March Against Hate in Dallas, Texas   •   Black & Veatch Distributed Infrastructure Business Awarded Highest OSHA Star Recognition
Bookmark and Share

Mycovia Pharmaceuticals CEO Patrick Jordan Named 2020 Life Sciences CEO of the Year by Triangle Business Journal

DURHAM, N.C. , August 06 /Businesswire/ - Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced Chief Executive Officer, Patrick Jordan, was named Life Sciences CEO of the Year by the Triangle Business Journal (TBJ). The prestigious regional TBJ Life Sciences Awards recognize individuals and research organizations that are blazing trails and breaking ground in the life sciences field. Mr. Jordan will be featured along with other winners in a special section of TBJ’s August 21 issue.

Mr. Jordan receives this award following an important year for Mycovia in which the company achieved multiple milestones in the development of its lead product candidate, oteseconazole, a novel oral therapy being studied for the treatment of recurrent vulvovaginal candidiasis (RVVC). The company completed enrollment ahead of schedule for its global phase 3 studies conducted in 11 countries, closed two transformational licensing agreements with Hengrui Medicine and Gedeon Richter, and was named the “Buzz of BIO” Late Stage Leader by the world’s largest biotech trade organization. Patrick has also recently led conversations with other industry executives about the need for increased investment for research and development in women’s health, including participating in panels at BIO-Europe 2019 last October and BIO Digital 2020 in June.

As CEO, Mr. Jordan leads Mycovia in its community involvement efforts. Over the past year, Mycovia has contributed to various initiatives in the Triangle, including supporting a local Durham elementary school with a BackPack Buddies program, instituting a company-wide employee volunteer day and sponsoring a triathlon event in Chapel Hill in October 2019 hosted by Ramblin’ Rose/Girls on the Run of the Triangle.

Mr. Jordan shared his thoughts on receiving this recognition, “I am deeply honored to receive this award and dedicate it to an outstanding team at Mycovia. This team inspires me through its passion, enlightens me with its insights, emboldens me by its courage, and drives me with its commitment. It is my genuine privilege to work together with this team to advance new therapies to address overlooked conditions affecting millions of people globally.”

About Mycovia Pharmaceuticals

Mycovia Pharmaceuticals has a passion for developing breakthrough therapies in areas of unmet medical need, with an initial focus in women’s health. Our lead product candidate, oteseconazole (VT-1161), is a novel, oral therapy for RVVC, that is designed with the goal of having greater selectivity, fewer side effects and improved efficacy. While not yet approved by the FDA, oteseconazole received FDA Qualified Infectious Disease Product and Fast-Track designations to support its potential to be the first FDA-approved treatment for RVVC. Oteseconazole is currently in Phase 3 clinical trials designed to establish its safety and efficacy in RVVC patients. In 2019, Mycovia licensed oteseconazole to Jiangsu Hengrui Medicine Co., to develop and commercialize oteseconazole in China, including mainland China, Hong Kong, Macau and Taiwan, and Gedeon Richter Plc., a Hungary-based pharmaceutical company, to commercialize and manufacture oteseconazole in Europe, Russia, the Commonwealth of Independent States, Latin America and Australia. Mycovia also recognizes a tremendous potential for its oral fungal inhibitors and a growing need to treat a range of multi-drug resistant fungal pathogens. For more information, please visit www.mycovia.com.

About Recurrent Vulvovaginal Candidiasis

RVVC is a debilitating, chronic infectious condition that affects millions of women. Primary symptoms include vaginal itching, burning, irritation and inflammation. Some women may experience abnormal vaginal discharge and painful sexual intercourse or urination, causing variable but often severe discomfort and pain. RVVC impacts quality of life, to a degree comparable to asthma and worse than diseases such as migraine.


STORY TAGS: Science, Women, Biotechnology, Research, Pharmaceutical, Health, Consumer, Clinical Trials, North Carolina, United States, North America, Personnel, Award,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News